お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:前立腺がん診断の世界市場:業界動向と予測 (~2028年)
市場調査レポート
商品コード
991814

前立腺がん診断の世界市場:業界動向と予測 (~2028年)

Global Prostate Cancer Diagnostics Market - Industry Trends and Forecast to 2028

出版日: | 発行: Data Bridge Market Research Private Limited | ページ情報: 英文 368 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
前立腺がん診断の世界市場:業界動向と予測 (~2028年)
出版日: 2021年01月01日
発行: Data Bridge Market Research Private Limited
ページ情報: 英文 368 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前立腺がん診断の市場規模は、2021年から2028年の予測期間に13.2%のCAGRを記録すると予測されています。同市場の成長に寄与する主な要因として、前立腺がん有病率の上昇による前立腺がん第二次診断市場の成長および高齢者人口の増加などが挙げられます。

当レポートでは、世界の前立腺がん診断市場について調査し、市場の概要とダイナミクス、各セグメント・地域別による市場規模の分析と予測、および主要企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 疫学

第5章 親市場との比較分析

第6章 規制の枠組み:世界の前立腺がん診断市場

  • 米国の規制シナリオ
  • 欧州連合の規制シナリオ
  • 日本の規制シナリオ
  • 中国の規制シナリオ

第7章 市場概要

  • 促進要因
    • 前立腺がんの有病率の上昇
    • 前立腺がんの診断における研究開発の増加
    • 高齢者人口の増加
    • 前立腺がん診断のための新製品の発売
    • 前立腺がんの原因となる病気
  • 抑制要因
    • PSAテストに関連する論争
    • 診断手順の高コスト
    • 熟練専門家・認定を受けた専門家の不足
  • 市場機会
    • 新興プレーヤーによる投資と資金調達の増加
    • 前立腺がんの診断のための償還方針
    • がんの診断に向けた政府のイニシアチブ
    • 前立腺がんの早期診断別生存率の上昇
  • 課題
    • 診断製品に対する厳格な規制要件
    • 診断テストの実施に直面した運用上の障壁
    • 不正確な診断結果

第8章 世界の前立腺がん診断市場におけるCOVID-19の影響

  • 価格への影響
  • 需要への影響
  • サプライチェーンへの影響
  • COVID-19パンデミック中に行われた製造業者による戦略的決定
  • COVID-19期間中の市場プレーヤーによる主なイニシアチブ
  • 結論

第9章 世界の前立腺がんの診断市場:製品タイプ別

  • 概要
  • 試薬&消耗品
  • 装置
  • 付属品

第10章 世界の前立腺がん診断市場:診断タイプ別

  • 概要
  • 予備スクリーニングテスト
    • 前立腺特異抗原(PSA)テスト
    • 直腸指診(DRE)テスト
  • 確認テスト
    • PCA3テスト
    • 生検
    • イメージングテスト
    • バイオマーカー

第11章 世界の前立腺がん診断市場:診断タイプ別

  • 概要
  • 前立腺腺がん
  • 小細胞がん
  • その他

第12章 世界の前立腺がん診断市場:年齢グループ別

  • 概要
  • 高齢者
  • 成人
  • 小児

第13章 世界の前立腺がん診断市場:病期別

  • 概要
  • 限局性立腺がん
  • 再発性/進行性前立腺がん
  • 去勢抵抗性前立腺がん(転移性および非転移性)

第14章 世界の前立腺がん診断市場:サンプルタイプ別

  • 概要
  • 血液
  • 組織
  • 尿
  • その他

第15章 世界の前立腺がん診断市場:エンドユーザー別

  • 概要
  • 独立診断研究所
  • 病院
  • クリニック
  • 通院外科診療所
  • がん研究機関
  • その他

第16章 世界の前立腺がん診断市場:流通経路別

  • 概要
  • 直接入札
  • 小売売上

第17章 世界の前立腺がん診断市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • スイス
    • オランダ
    • トルコ
    • ベルギー
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • シンガポール
    • タイ
    • マレーシア
    • インドネシア
    • フィリピン
    • アジア太平洋-太平洋
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • エジプト
    • その他中東・アフリカ

第18章 世界の前立腺がん診断市場:企業情勢

  • 企業シェア分析:世界
  • 企業シェア分析:北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋

第19章 SWOT

第20章 企業プロファイル

  • F. HOFFMANN-LA ROCHE LTD
  • ABBOTT
  • SIEMENS HEALTHCARE GMBH
  • OPKO HEALTH INC.
  • BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
  • ACCUQUIK TEST KITS
  • ACON LABORATORIES INC.
  • BIOMERIEUX SA
  • DIASORIN S.P.A
  • EUROLYSER DIAGNOSTICA GMBH
  • FUJIREBIO
  • GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
  • HOLOGIC, INC.
  • HUMASIS
  • MDXHEALTHCARE
  • METAMARK GENETICS, INC.
  • MYRAID GENETICS, INC.
  • PROSTATYPE GENOMICS
  • PROTEOMEDIX
  • TECO DIAGNOSTICS

第21章 アンケート

第22章 関連レポート

図表

LIST OF TABLES

  • TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988
  • TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER
  • TABLE 3 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 2019-2028 (USD MILLION)
  • TABLE 4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 2019-2028 (UNITS)
  • TABLE 5 GLOBAL REAGENTS & CONSUMABLES IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 6 GLOBAL INSTRUMENTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 7 GLOBAL ACCESSORIES IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 8 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 GLOBAL PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 10 GLOBAL CONFIRMATORY TESTSIN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 11 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 12 GLOBAL PROSTATIC ADENOCARCINOMAS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE 2019-2028 (USD MILLION), BY REGION
  • TABLE 13 GLOBAL SMALL CELL CARCINOMA IN PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 14 GLOBAL OTHERS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 15 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP 2019-2028 (USD MILLION)
  • TABLE 16 GLOBAL GERIATRICS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION 2019-2028 (USD MILLION)
  • TABLE 17 GLOBAL SEVERE IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 18 GLOBAL SEVERE IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 19 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 20 GLOBAL LOCALIZED PROSTATE CANCER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 21 GLOBAL RECURRENT/ADVANCED PROSTATE CANCER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 22 GLOBAL CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 23 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 24 GLOBAL BLOOD IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 25 GLOBAL TISSUE IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 26 GLOBAL URINE IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 27 GLOBAL OTHERS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 28 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 29 GLOBAL INDEPENDENT DIAGNOSTIC LABORATORIES IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 30 GLOBAL HOSPITALS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 31 GLOBAL CLINICS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 32 GLOBAL AMBULATORY SURGICAL CENTERS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 33 GLOBAL CANCER RESEARCH INSTITUTES IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 34 GLOBAL OTHERS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 35 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 36 GLOBAL DIRECT TENDER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 37 GLOBAL HOSPITALS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 40 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 41 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 42 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 43 NORTH AMERICA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 44 NORTH AMERICA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 46 NORTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 48 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 49 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 50 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 54 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 55 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 56 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 57 U.S. PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 58 U.S. CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 59 U.S. IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 60 U.S. MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 61 U.S. BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 62 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 63 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 64 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 65 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 66 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 67 U.S. PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 68 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 69 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 70 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 71 CANADA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 72 CANADA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 73 CANADA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 74 CANADA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 75 CANADA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 76 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 77 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 78 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 79 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 80 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 81 CANADA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 82 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 83 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 84 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 85 MEXICO PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 86 MEXICO CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 87 MEXICO IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 88 MEXICO MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 89 MEXICO BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 90 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 91 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 92 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 93 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 94 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 95 MEXICO PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 96 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 97 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 98 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 99 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 100 EUROPE PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 101 EUROPE CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 102 EUROPE IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 103 EUROPE MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 104 EUROPE BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 105 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 106 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 107 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 108 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 109 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 110 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 111 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 112 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 113 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 114 GERMANY PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 115 GERMANY CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 116 GERMANY IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 117 GERMANY MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 118 GERMANY BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 119 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 120 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 121 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 122 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 123 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 124 GERMANY PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 125 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 126 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 127 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 128 FRANCE PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 129 FRANCE CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 130 FRANCE IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 131 FRANCE MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 132 FRANCE BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 133 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 134 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 135 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 136 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 137 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 138 FRANCE PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 139 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 140 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 141 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 142 U.K. PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 143 U.K. CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 144 U.K. IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 145 U.K. MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 146 U.K. BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 147 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 148 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 149 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 150 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 151 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 152 U.K. PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 153 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 154 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 155 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 156 ITALY PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 157 ITALY CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 158 ITALY IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 159 ITALY MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 160 ITALY BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 161 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 162 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 163 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 164 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 165 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 166 ITALY PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 167 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 168 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 169 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 170 SPAIN PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 171 SPAIN CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 172 SPAIN IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 173 SPAIN MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 174 SPAIN BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 175 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 176 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 177 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 178 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 179 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 180 SPAIN PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 181 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 182 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 183 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 184 RUSSIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 185 RUSSIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 186 RUSSIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 187 RUSSIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 188 RUSSIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 189 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 190 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 191 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 192 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 193 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 194 RUSSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 195 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 196 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 197 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 198 SWITZERLAND PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 199 SWITZERLAND CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 200 SWITZERLAND IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 201 SWITZERLAND MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 202 SWITZERLAND BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 203 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 204 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 205 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 206 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 207 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 208 SWITZERLAND PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 209 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 210 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 211 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 212 NETHERLANDS PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 213 NETHERLANDS CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 214 NETHERLANDS IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 215 NETHERLANDS MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 216 NETHERLANDS BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 217 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 218 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 219 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 220 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 221 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 222 NETHERLANDS PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 223 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 224 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 225 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 226 TURKEY PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 227 TURKEY CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 228 TURKEY IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 229 TURKEY MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 230 TURKEY BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 231 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 232 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 233 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 234 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 235 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 236 TURKEY PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 237 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 238 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 239 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 240 BELGIUM PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 241 BELGIUM CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 242 BELGIUM IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 243 BELGIUM MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 244 BELGIUM BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 245 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 246 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 247 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 248 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 249 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 250 BELGIUM PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 251 REST OF EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 252 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 253 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 254 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 255 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 256 ASIA - PACIFIC PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 257 ASIA - PACIFIC CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 258 ASIA - PACIFIC IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 259 ASIA - PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 260 ASIA - PACIFIC BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 261 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 262 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 263 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 264 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 265 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 266 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 267 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 268 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 269 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 270 CHINA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 271 CHINA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 272 CHINA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 273 CHINA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 274 CHINA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 275 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 276 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 277 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 278 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 279 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 280 CHINA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 281 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 282 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 283 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 284 JAPAN PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 285 JAPAN CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 286 JAPAN IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 287 JAPAN MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 288 JAPAN BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 289 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 290 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 291 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 292 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 293 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 294 JAPAN PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 295 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 296 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 297 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 298 INDIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 299 INDIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 300 INDIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 301 INDIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 302 INDIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 303 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 304 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 305 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 306 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 307 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 308 INDIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 309 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 310 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 311 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 312 AUSTRALIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 313 AUSTRALIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 314 AUSTRALIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 315 AUSTRALIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 316 AUSTRALIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 317 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 318 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 319 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 320 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 321 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 322 AUSTRALIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 323 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 324 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 325 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 326 SOUTH KOREA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 327 SOUTH KOREA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 328 SOUTH KOREA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 329 SOUTH KOREA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 330 SOUTH KOREA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 331 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 332 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 333 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 334 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 335 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 336 SOUTH KOREA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 337 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 338 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 339 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 340 SINGAPORE PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 341 SINGAPORE CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 342 SINGAPORE IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 343 SINGAPORE MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 344 SINGAPORE BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 345 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 346 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 347 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 348 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 349 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 350 SINGAPORE PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 351 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 352 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 353 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 354 THAILAND PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 355 THAILAND CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 356 THAILAND IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 357 THAILAND MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 358 THAILAND BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 359 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 360 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 361 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 362 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 363 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 364 THAILAND PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 365 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 366 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 367 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 368 MALAYSIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 369 MALAYSIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 370 MALAYSIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 371 MALAYSIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 372 MALAYSIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 373 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 374 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 375 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 376 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 377 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 378 MALAYSIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 379 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 380 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 381 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 382 INDONESIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 383 INDONESIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 384 INDONESIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 385 INDONESIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 386 INDONESIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 387 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 388 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 389 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 390 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 391 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 392 INDONESIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 393 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 394 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 395 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 396 PHILIPPINES PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 397 PHILIPPINES CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 398 PHILIPPINES IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 399 PHILIPPINES MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 400 PHILIPPINES BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 401 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 402 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 403 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 404 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 405 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 406 PHILIPPINES PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 407 REST OF ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 408 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 409 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 410 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 411 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 412 SOUTH AMERICA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 413 SOUTH AMERICA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 414 SOUTH AMERICA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 415 SOUTH AMERICA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 416 SOUTH AMERICA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 417 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 418 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 419 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 420 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 421 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 422 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 423 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 424 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 425 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 426 BRAZIL PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 427 BRAZIL CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 428 BRAZIL IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 429 BRAZIL MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 430 BRAZIL BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 431 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 432 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 433 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 434 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 435 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 436 BRAZIL PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 437 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 438 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 439 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 440 ARGENTINA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 441 ARGENTINA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 442 ARGENTINA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 443 ARGENTINA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 444 ARGENTINA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 445 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 446 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 447 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 448 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 449 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 450 ARGENTINA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 451 REST OF SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 452 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 453 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 454 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 455 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 456 MIDDLE EAST & AFRICA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 457 MIDDLE EAST & AFRICA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 458 MIDDLE EAST & AFRICA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 459 MIDDLE EAST & AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 460 MIDDLE EAST & AFRICA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 461 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 462 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 463 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 464 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 465 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 466 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 467 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 468 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 469 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 470 SOUTH AFRICA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 471 SOUTH AFRICA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 472 SOUTH AFRICA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 473 SOUTH AFRICA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 474 SOUTH AFRICA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 475 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 476 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 477 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 478 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 479 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 480 SOUTH AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 481 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 482 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 483 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 484 SAUDI ARABIA PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 485 SAUDI ARABIA CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 486 SAUDI ARABIA IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 487 SAUDI ARABIA MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 488 SAUDI ARABIA BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 489 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 490 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 491 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 492 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 493 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 494 SAUDI ARABIA PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 495 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 496 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 497 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 498 UAE PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 499 UAE CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 500 UAE IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 501 UAE MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 502 UAE BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 503 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 504 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 505 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 506 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 507 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 508 UAE PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 509 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 510 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 511 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 512 ISRAEL PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 513 ISRAEL CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 514 ISRAEL IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 515 ISRAEL MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 516 ISRAEL BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 517 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 518 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 519 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 520 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 521 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 522 ISRAEL PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 523 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 524 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (UNITS)
  • TABLE 525 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 526 EGYPT PRELIMINARY SCREENING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 527 EGYPT CONFIRMATORY TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 528 EGYPT IMAGING TESTS IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 529 EGYPT MAGNETIC RESONANCE IMAGING (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 530 EGYPT BIOMARKER IN PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE, 2019-2028 (USD MILLION)
  • TABLE 531 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
  • TABLE 532 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 533 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 534 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 535 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS, 2019-2028 (USD MILLION)
  • TABLE 536 EGYPT PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 537 REST OF MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION
  • FIGURE 2: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET : DATA TRIANGULATION
  • FIGURE 3: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
  • FIGURE 4: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING
  • FIGURE 7: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MARKET END USERS COVERAGE GRID
  • FIGURE 10: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION
  • FIGURE 12: NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS GROWING AT THE FASTEST PACE IN THE GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 13: INCREASING PREVALENCE OF PROSTATE CANCER AND INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICS ARE DRIVING THE GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 14: REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET IN 2021 & 2028
  • FIGURE 15: ASIA-PACIFIC IS THE FASTEST GROWING MARKET IN GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 16: REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA
  • FIGURE 17: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
  • FIGURE 18: ESTIMATED INCIDENCE CASES OF PROSTATE CANCER, ALL AGES
  • FIGURE 19: GERIATRIC POPULATION IN THE EUROPEAN REGION
  • FIGURE 20: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2020
  • FIGURE 21: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
  • FIGURE 22: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
  • FIGURE 23: PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
  • FIGURE 24: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020
  • FIGURE 25: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2020-2028 (USD MILLION)
  • FIGURE 26: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)
  • FIGURE 27: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE
  • FIGURE 28: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY TYPE, 2020
  • FIGURE 29: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
  • FIGURE 30: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY TYPE, CAGR (2020-2028)
  • FIGURE 31: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 32: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2020
  • FIGURE 33: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY AGE GROUP , 2020-2028 (USD MILLION)
  • FIGURE 34: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2021-2028)
  • FIGURE 35: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE
  • FIGURE 36: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY STAGE, 2020
  • FIGURE 37: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
  • FIGURE 38: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
  • FIGURE 39: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
  • FIGURE 40: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY SAMPLE TYPE, 2020
  • FIGURE 41: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY SAMPLE TYPE, 2020-2028 (USD MILLION)
  • FIGURE 42: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY SAMPLE TYPE, CAGR (2021-2028)
  • FIGURE 43: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY SAMPLE TYPE, LIFELINE CURVE
  • FIGURE 44: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY END USERS, 2020
  • FIGURE 45: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY END USERS, 2020-2028 (USD MILLION)
  • FIGURE 46: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY END USERS, CAGR (2021-2028)
  • FIGURE 47: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY END USERS, LIFELINE CURVE
  • FIGURE 48: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 49: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
  • FIGURE 50: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 51: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION, LIFELINE CURVE
  • FIGURE 52: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 53: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 54: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 55: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 56: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2020-2028)
  • FIGURE 57: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 58: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 59: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 60: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 61: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 62: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 63: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 64: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 65: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 66: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 67: ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 68: ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 69: ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 70: ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 71: ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 72: SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 73: SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 74: SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 75: SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 76: SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 77: MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)
  • FIGURE 78: MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)
  • FIGURE 79: MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 80: MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 81: MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 82: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)
  • FIGURE 83: NORTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)
  • FIGURE 84: EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)
  • FIGURE 85: ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)
目次

Global prostate cancer diagnostics market is projected to register a CAGR of 13.2% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Global Prostate Cancer Diagnostics Market, By Product Type (Instruments, Reagents & Consumables and Accessories), Diagnostics Type (Preliminary Screening Tests, Confirmatory Tests), Age Group (Adult, Pediatric and Geriatrics), Type (Prostatic Adenocarcinoma, Small Cell Carcinoma and Others), Stage (Localized Prostate Cancer, Recurrent/Advanced Prostate Cancer and Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic), Sample Type (Blood, Tissue, Urine and Others), End Users (Independent Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, U.K., Italy, Spain, Russia, Switzerland, Netherlands, Belgium, Turkey, Ireland and Rest of Europe, Japan, China, Australia, South Korea, India, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, U.S., Canada, Mexico, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, UAE, Israel and Rest of Middle East and Africa)-Industry Trends & Forecast to 2028.

Some of the major factors contributing to the growth of the global prostate cancer diagnostics market are:

  • The secondary prostate cancer diagnostics market is growing due to increasing prevalence of prostate cancer
  • Increase in geriatric population

Market Players

The key market players for the global prostate cancer diagnostics market are listed below:

  • FF. Hoffmann-La Roche Ltd
  • ACON Laboratories, Inc.
  • HUMASIS
  • Teco Diagnostics
  • Hologic Inc.
  • Accuquik Test Kits
  • MDxHealthcare
  • Abbott
  • Siemens Healthcare GmbH
  • OPKO Health Inc.
  • Myraid Genetics, Inc.
  • DiaSorin S.p.A
  • Beckman Coulter, Inc. (a subsidiary of Danaher)
  • Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation)
  • bioMerieux SA
  • Metamark Genetics, Inc.
  • Prostatype Genomics
  • Fujirebio
  • Proteomedix
  • Eurolyser Diagnostica GmbH

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. MULTIVARIATE MODELLING
  • 2.7. PRODUCT TYPE LIFELINE CURVE
  • 2.8. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9. DBMR MARKET POSITION GRID
  • 2.10. MARKET END USERS COVERAGE GRID
  • 2.11. VENDOR SHARE ANALYSIS
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. EPIDEMIOLOGY

5. COMPARATIVE ANALYSIS WITH PARENT MARKET

6. REGULATORY FRAMEWORK: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET

  • 6.1. REGULATORY SCENARIO IN THE U.S.
  • 6.2. REGULATORY SCENARIO IN EUROPEAN UNION
  • 6.3. REGULATORY SCENARIO IN JAPAN
  • 6.4. REGULATORY SCENARIO IN CHINA

7. MARKET OVERVIEW

  • 7.1. DRIVERS
    • 7.1.1. INCREASING PREVALENCE OF PROSTATE CANCER
    • 7.1.2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
    • 7.1.3. INCREASE IN GERIATRIC POPULATION
    • 7.1.4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
    • 7.1.5. DISEASE CAUSING PROSTATE CANCER
  • 7.2. RESTRAINTS
    • 7.2.1. CONTROVERSY RELATED TO PSA TESTING
    • 7.2.2. HIGH COST OF DIAGNOSTICS PROCEDURE
    • 7.2.3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
  • 7.3. OPPORTUNITIES
    • 7.3.1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
    • 7.3.2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
    • 7.3.3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
    • 7.3.4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
  • 7.4. CHALLENGES
    • 7.4.1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
    • 7.4.2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
    • 7.4.3. INACCURATE DIAGNOSIS RESULTS

8. IMPACT OF COVID-19 ON GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET

  • 8.1. IMPACT ON PRICE
  • 8.2. IMPACT ON DEMAND
  • 8.3. IMPACT ON SUPPLY CHAIN
  • 8.4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
  • 8.5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
  • 8.6. CONCLUSION

9. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 9.1. OVERVIEW
  • 9.2. REAGENTS & CONSUMABLES
  • 9.3. INSTRUMENTS
  • 9.4. ACCESSORIES

10. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE

  • 10.1. OVERVIEW
  • 10.2. PRELIMINARY SCREENING TESTS
    • 10.2.1. PROSTATE-SPECIFIC ANTIGEN (PSA) TEST
    • 10.2.2. DIGITAL RECTAL EXAM (DRE) TEST
  • 10.3. CONFIRMATORY TESTS
    • 10.3.1. PCA3 TEST
    • 10.3.2. BIOPSY
    • 10.3.3. IMAGING TESTS
      • 10.3.3.1. ULTRASOUND
      • 10.3.3.2. MAGNETIC RESONANCE IMAGING (MRI)
        • 10.3.3.2.1. MULTIPARAMETRIC MRI
        • 10.3.3.2.2. MRI FUSION-GUIDED PROSTATE BIOPSY
      • 10.3.3.3. CT SCAN
      • 10.3.3.4. BONE SCAN
      • 10.3.3.5. PET/CT SCAN
    • 10.3.4. BIOMARKER
      • 10.3.4.1. RNA BIOMARKERS
      • 10.3.4.2. DNA BIOMARKERS
      • 10.3.4.3. PROTEIN BIOMARKERS

11. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY TYPE

  • 11.1. OVERVIEW
  • 11.2. PROSTATIC ADENOCARCINOMA
  • 11.3. SMALL CELL CARCINOMA
  • 11.4. OTHERS

12. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP

  • 12.1. OVERVIEW
  • 12.2. GERIATRICS
  • 12.3. ADULT
  • 12.4. PEDIATRIC

13. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY STAGE

  • 13.1. OVERVIEW
  • 13.2. LOCALIZED PROSTATE CANCER
  • 13.3. RECURRENT/ADVANCED PROSTATE CANCER
  • 13.4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)

14. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY SAMPLE TYPE

  • 14.1. OVERVIEW
  • 14.2. BLOOD
  • 14.3. TISSUE
  • 14.4. URINE
  • 14.5. OTHERS

15. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY END USERS

  • 15.1. OVERVIEW
  • 15.2. INDEPENDENT DIAGNOSTIC LABORATORIES
  • 15.3. HOSPITALS
  • 15.4. CLINICS
  • 15.5. AMBULATORY SURGICAL CENTERS
  • 15.6. CANCER RESEARCH INSTITUTES
  • 15.7. OTHERS

16. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL

  • 16.1. OVERVIEW
  • 16.2. DIRECT TENDER
  • 16.3. RETAIL SALES

17. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY

  • 17.1. OVERVIEW
  • 17.2. NORTH AMERICA
    • 17.2.1. U.S.
    • 17.2.2. CANADA
    • 17.2.3. MEXICO
  • 17.3. EUROPE
    • 17.3.1. GERMANY
    • 17.3.2. FRANCE
    • 17.3.3. U.K.
    • 17.3.4. ITALY
    • 17.3.5. SPAIN
    • 17.3.6. RUSSIA
    • 17.3.7. SWITZERLAND
    • 17.3.8. NETHERLANDS
    • 17.3.9. TURKEY
    • 17.3.10. BELGIUM
    • 17.3.11. REST OF EUROPE
  • 17.4. ASIA - PACIFIC
    • 17.4.1. CHINA
    • 17.4.2. JAPAN
    • 17.4.3. INDIA
    • 17.4.4. AUSTRALIA
    • 17.4.5. SOUTH KOREA
    • 17.4.6. SINGAPORE
    • 17.4.7. THAILAND
    • 17.4.8. MALAYSIA
    • 17.4.9. INDONESIA
    • 17.4.10. PHILIPPINES
    • 17.4.11. REST OF ASIA - PACIFIC
  • 17.5. SOUTH AMERICA
    • 17.5.1. BRAZIL
    • 17.5.2. ARGENTINA
    • 17.5.3. REST OF SOUTH AMERICA
  • 17.6. MIDDLE EAST & AFRICA
    • 17.6.1. SOUTH AFRICA
    • 17.6.2. SAUDI ARABIA
    • 17.6.3. UAE
    • 17.6.4. ISRAEL
    • 17.6.5. EGYPT
    • 17.6.6. REST OF MIDDLE EAST & AFRICA

18. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE

  • 18.1. COMPANY SHARE ANALYSIS: GLOBAL
  • 18.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 18.3. COMPANY SHARE ANALYSIS: EUROPE
  • 18.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC

19. SWOT

20. COMPANY PROFILE

  • 20.1. F. HOFFMANN-LA ROCHE LTD
    • 20.1.1. COMPANY SNAPSHOT
    • 20.1.2. REVENUE ANALYSIS
    • 20.1.3. COMPANY SHARE ANALYSIS
    • 20.1.4. PRODUCT PORTFOLI0
    • 20.1.5. RECENT DEVELOPMENTS
  • 20.2. ABBOTT
    • 20.2.1. COMPANY SNAPSHOT
    • 20.2.2. REVENUE ANALYSIS
    • 20.2.3. COMPANY SHARE ANALYSIS
    • 20.2.4. PRODUCT PORTFOLIO
    • 20.2.5. RECENT DEVELOPMENTS
  • 20.3. SIEMENS HEALTHCARE GMBH
    • 20.3.1. COMPANY SNAPSHOT
    • 20.3.2. REVENUE ANALYSIS
    • 20.3.3. COMPANY SHARE ANALYSIS
    • 20.3.4. PRODUCT PORTFOLIO
    • 20.3.5. RECENT DEVELOPMENTS
  • 20.4. OPKO HEALTH INC.
    • 20.4.1. COMPANY SNAPSHOT
    • 20.4.2. REVENUE ANALYSIS
    • 20.4.3. COMPANY SHARE ANALYSIS
    • 20.4.4. PRODUCT PORTFOLIO
    • 20.4.5. RECENT DEVELOPMENTS
  • 20.5. BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
    • 20.5.1. COMPANY SNAPSHOT
    • 20.5.2. REVENUE ANALYSIS
    • 20.5.3. COMPANY SHARE ANALYSIS
    • 20.5.4. PRODUCT PORTFOLIO
    • 20.5.5. RECENT DEVELOPMENTS
  • 20.6. ACCUQUIK TEST KITS
    • 20.6.1. COMPANY SNAPSHOT
    • 20.6.2. PRODUCT PORTFOLIO
    • 20.6.3. RECENT DEVELOPMENT
  • 20.7. ACON LABORATORIES INC.
    • 20.7.1. COMPANY SNAPSHOT
    • 20.7.2. PRODUCT PORTFOLIO
    • 20.7.3. RECENT DEVELOPMENTS
  • 20.8. BIOMERIEUX SA
    • 20.8.1. COMPANY SNAPSHOT
    • 20.8.2. REVENUE ANALYSIS
    • 20.8.3. PRODUCT PORTFOLIO
    • 20.8.4. RECENT DEVELOPMENT
  • 20.9. DIASORIN S.P.A
    • 20.9.1. COMPANY SNAPSHOT
    • 20.9.2. REVENUE ANALYSIS
    • 20.9.3. PRODUCT PORTFOLI0
    • 20.9.4. RECENT DEVELOPMENTS
  • 20.10. EUROLYSER DIAGNOSTICA GMBH
    • 20.10.1. COMPANY SNAPSHOT
    • 20.10.2. PRODUCT PORTFOLIO
    • 20.10.3. RECENT DEVELOPMENT
  • 20.11. FUJIREBIO
    • 20.11.1. COMPANY SNAPSHOT
    • 20.11.2. PRODUCT PORTFOLI
    • 20.11.3. RECENT DEVELOPMENTS
  • 20.12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
    • 20.12.1. COMPANY SNAPSHOT
    • 20.12.2. REVENUE ANALYSIS
    • 20.12.3. PRODUCT PORTFOLIO
    • 20.12.4. RECENT DEVELOPMENTS
  • 20.13. HOLOGIC, INC.
    • 20.13.1. COMPANY SNAPSHOT
    • 20.13.2. REVENUE ANALYSIS
    • 20.13.3. PRODUCT PORTFOLIO
    • 20.13.4. RECENT DEVELOPMENTS
  • 20.14. HUMASIS
    • 20.14.1. COMPANY SNAPSHOT
    • 20.14.2. PRODUCT PORTFOLIO
    • 20.14.3. RECENT DEVELOPMENTS
  • 20.15. MDXHEALTHCARE
    • 20.15.1. COMPANY SNAPSHOT
    • 20.15.2. REVENUE ANALYSIS
    • 20.15.3. PRODUCT PORTFOLIO
    • 20.15.4. RECENT DEVELOPMENTS
  • 20.16. METAMARK GENETICS, INC.
    • 20.16.1. COMPANY SNAPSHOT
    • 20.16.2. PRODUCT PORTFOLI0
    • 20.16.3. RECENT DEVELOPMENTS
  • 20.17. MYRAID GENETICS, INC.
    • 20.17.1. COMPANY SNAPSHOT
    • 20.17.2. REVENUE ANALYSIS
    • 20.17.3. PRODUCT PORTFOLIO
    • 20.17.4. RECENT DEVELOPMENTS
  • 20.18. PROSTATYPE GENOMICS
    • 20.18.1. COMPANY SNAPSHOT
    • 20.18.2. REVENUE ANALYSIS
    • 20.18.3. PRODUCT PORTFOLIO
    • 20.18.4. RECENT DEVELOPMENTS
  • 20.19. PROTEOMEDIX
    • 20.19.1. COMPANY SNAPSHOT
    • 20.19.2. PRODUCT PORTFOLIO
    • 20.19.3. RECENT DEVELOPMENTS
  • 20.20. TECO DIAGNOSTICS
    • 20.20.1. COMPANY SNAPSHOT
    • 20.20.2. PRODUCT PORTFOLIO
    • 20.20.3. RECENT DEVELOPMENT

21. QUESTIONNAIRE

22. RELATED REPORTS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.